Clinical Pharmacology of Pentoxifylline With Special Reference to Its Hemorrheologic Effect for the Treatment of Intermittent Claudication
- 2 January 1985
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 25 (1), 8-26
- https://doi.org/10.1002/j.1552-4604.1985.tb02796.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Placebo Controlled Double Blind Study with Pentoxifylline of Walking Performance in Patients with Intermittent ClaudicationAngiology, 1983
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: Results of double-blind study versus vasodilator-nylidrinAmerican Heart Journal, 1982
- Effects of continuous administration of dietary theobromine on rat testicular weight and morphologyToxicology and Applied Pharmacology, 1981
- The mechanical and biochemical effects of pentoxifylline on the perfused rat heartCellular and Molecular Life Sciences, 1980
- Metabolic pathway of theobromine in the rat and identification of two new metabolites in human urineJournal of Agricultural and Food Chemistry, 1979
- Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial diseaseCurrent Medical Research and Opinion, 1979
- Improvement of the Flow Properties of Blood: a New Therapeutical Approach in Occlusive Arterial DiseaseAngiology, 1976
- The influence of l-(5-oxohexyl-)3.7-dimethylxanthine (BL 191) on the endocrine and exocrine pancreatic function in man during and following secretin and cholecystokinin-pancreozymin stimulationZeitschrift für Die Gesamte Experimentelle Medizin, 1973
- THE CASE AGAINST VASODILATOR DRUGS IN OCCLUSIVE VASCULAR DISEASE OF THE LEGSThe Lancet, 1959